Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR)

CUSIP: 471871202

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 5 signals
Share change
-1
SEC-reported price per share
$0.42
Number of holders
1
Value change
$0
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
33,902,298

Security key

471871202

Report period

Q2 2026

Institutions

1

Top holders

1

Ownership snapshot

Top reported holders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
T. Rowe Price Investment ...
Disclosed value leader
Velan Capital Investment ...
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G 13F 3/4/5 Lead comparable stake: 7.1% 13D/G row: T. Rowe Price Investment Management, Inc. Showing 1-6 of 15 holder rows.

Quick read

T. Rowe Price Investment Management, Inc. leads the comparable SEC ownership view at 7.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens T. Rowe Price Investment Management, Inc.'s linked filing trail.
Comparable ownership Top 5
T. Rowe Price Investment Manageme... 7.1%
ACORN BIOVENTURES, L.P. 5.3%
MORGAN STANLEY 4.8%
KINGDON CAPITAL MANAGEMENT, L.L.C. 4.7%
Carlyle Group Inc. 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
T. Rowe Price Investment Management, Inc.
13D/G
7.1%
$4,897,117
2,057,612 shares
$0 30 Sep 2025
ACORN BIOVENTURES, L.P.
13D/G
Anders Hove
5.3%
$2,660,821
1,486,492 shares
-$537,000 23 Jan 2026
MORGAN STANLEY
13D/G 13F
Company
4.8%
$1,226,746
1,333,420 shares
-$585,456 31 Mar 2026
KINGDON CAPITAL MANAGEMENT, L.L.C.
13D/G 13F
Company
4.7%
$3,153,131
1,324,845 shares
+$1,332,431 30 Sep 2025
Carlyle Group Inc.
3/4/5 13D/G 13F
Former 10% Owner · The Carlyle Group Inc. · Company
3.8%
from 13D/G
$13,807,148
1,066,189 shares
08 Feb 2024
Qiming U.S. Healthcare Fund II, L.P.
3/4/5 13D/G
10%+ Owner
3.3%
from 13D/G
$5,525,844
8,519,648 shares
27 Jan 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
64
Rows available
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
57
Q2 2026 holders
1
Holder diff
-56
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .